Items where authors include "Brown, J.M."

Article

Bolton, W.S. orcid.org/0000-0001-8451-9595, Aruparayil, N. orcid.org/0000-0002-2898-772X, Bundu, I. et al. (6 more authors) (2024) VITAL: an IDEAL stage 2b feasibility study of a randomised controlled trial evaluating whether virtual reality technology can improve surgical training in Sierra Leone. Journal of Surgical Simulation, 10 (1). pp. 59-68. ISSN 2051-7726

de Tute, R.M., Cook, G. orcid.org/0000-0003-1717-0412, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation. ISSN 0268-3369

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Corrigan, N. orcid.org/0000-0002-1424-9830, Brown, J.M. orcid.org/0000-0002-2719-7064, Emsley, R. et al. (2 more authors) (2023) Surgical trial design for incorporating the effects of learning: what is the current methodological guidance, and is it sufficient? Trials, 24. 294. ISSN 1745-6215

Snowden, J.A. orcid.org/0000-0001-6819-3476, Ahmedzai, S.H., Cox, A. orcid.org/0000-0002-5138-1099 et al. (9 more authors) (2022) Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study. Bone Marrow Transplantation, 57 (10). pp. 1507-1513. ISSN 0268-3369

Retzer, A., Calvert, M., Ahmed, K. et al. (15 more authors) (2021) International perspectives on suboptimal patient‐reported outcome trial design and reporting in cancer clinical trials : a qualitative study. Cancer Medicine, 10 (16). pp. 5475-5487. ISSN 2045-7634

Slade, A.L., Retzer, A., Ahmed, K. et al. (13 more authors) (2021) Systematic review of the use of translated patient-reported outcome measures in cancer trials. Trials, 22. 306. ISSN 1745-6215

Jayne, D.G., Williams, A.E., Corrigan, N. et al. (16 more authors) (2021) Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCT. Health Technology Assessment, 25 (18). ISSN 1366-5278

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Gordon, K., Collinson, M. et al. (14 more authors) (2021) Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study. Journal of Clinical Oncology, 39 (3). pp. 202-214. ISSN 0732-183X

Walsh, J.S. orcid.org/0000-0002-7122-2650, Marshall, H., Smith, I.L. et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors : a 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277

Kyte, D., Retzer, A., Ahmed, K. et al. (16 more authors) (2019) Systematic evaluation of patient-reported outcome protocol content and reporting in cancer trials. JNCI: Journal of the National Cancer Institute, 111 (11). pp. 1170-1178. ISSN 0027-8874

Ahmedzai, S.H., Snowden, J.A. orcid.org/0000-0001-6819-3476, Ashcroft, A.J. et al. (19 more authors) (2019) Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology, 37 (19). pp. 1617-1628. ISSN 0732-183X

Retzer, A., Keeley, T., Ahmed, K. et al. (16 more authors) (2018) Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials : the EPiC study qualitative protocol. BMJ Open, 8 (2). e017282.

Oughton, J.B. orcid.org/0000-0002-2047-804X, Poad, H., Twiddy, M. et al. (14 more authors) (2017) Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study. BMJ Open, 7 (8). e017913.

Cook, G., Ashcroft, A.J., Cairns, D.A. et al. (17 more authors) (2016) The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. Lancet Haematol, 3 (7). e340-e351.

Parrish, C., Morris, C.T.C.M., Williams, C.D. et al. (13 more authors) (2016) Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial. Biology of Blood and Marrow Transplantation, 22 (6). pp. 1009-1016. ISSN 1083-8791

Williams, A.E. orcid.org/0000-0001-8832-6686, Croft, J., Napp, V. et al. (7 more authors) (2016) SaFaRI: sacral nerve stimulation versus the FENIX magnetic sphincter augmentation for adult faecal incontinence: a randomised investigation. International Journal of Colorectal Disease, 31 (2). pp. 465-472.

Blencowe, N.S., Brown, J.M., Cook, J.A. et al. (7 more authors) (2015) Interventions in randomised controlled trials in surgery: issues to consider during trial design. Trials, 16. 392. ISSN 1745-6215

Hall, G.D., Brown, J.M., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (8 more authors) (2004) Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study. British Journal of Cancer, 91 (4). pp. 621-626. ISSN 0007-0920